Made Scientific will use RoosterBio's off-the-shelf MSCs, MSC expansion media, EV collection media, and related bioprocess expertise into its GMP operations.
The 38 projects include work in diabetes, cancer, Parkinson's disease, stroke, sickle cell disease, chronic pain, and cardiovascular, bone, blood, digestive, and neurological disorders
The company is working on iPSC-derived, AAV, and small molecule therapies for neurodegenerative, orthopedic, and blood-based disorders, with the help of OpenAI's models which seem to be accelerating life science research.
Cartherics is developing multiple immune cell therapies for women's health, including its lead candidate, CTH-401, a CAR-NK therapy targeting ovarian cancer.
As MEDIPOST ventures abroad, Charles River will provide GMP-compliant biologics and cell therapy testing services to help advance the pipeline into new markets.
The partnership combines Dark Horse's regulatory and development consulting with KunTuo's on-the-ground clinical trial execution to help companies launch studies faster and generate data to support regulatory submissions.
The trial demonstrated that Cartistem can both relieve symptoms and regenerate cartilage, and the company is advancing manufacturing readiness for its first overseas commercialization move.
Cellares said its automated Cell Shuttle platform successfully produced GMP-compliant rese-cel doses for Cabaletta Bio’s RESET trial, marking an early proof point that automation can help lower costs and scale autologous CAR...
The Gibco CTS DynaXS Single Use Bioreactor is designed to help cell therapy developers scale from process development to cGMP-ready clinical manufacturing with greater flexibility, process control, and support for diverse applications...
Cellular Intelligence will use its AI platform to speed the clinical development and scalable manufacturing of a Phase 1/2 stem cell-derived Parkinson’s therapy acquired from Novo Nordisk, which also took an equity...
